BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36208153)

  • 1. Microscopic Features of Vaginectomy Specimens from Transgender Patients.
    Dasaraju S; Klein ME; Murugan P; Farooqui M; Khalifa MA
    Am J Clin Pathol; 2022 Nov; 158(5):639-645. PubMed ID: 36208153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostatic metaplasia of the vagina in transmasculine individuals.
    Xu R; Diamond DA; Borer JG; Estrada C; Yu R; Anderson WJ; Vargas SO
    World J Urol; 2022 Mar; 40(3):849-855. PubMed ID: 35034167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic Metaplasia of the Vagina and Uterine Cervix: An Androgen-associated Glandular Lesion of Surface Squamous Epithelium.
    Anderson WJ; Kolin DL; Neville G; Diamond DA; Crum CP; Hirsch MS; Vargas SO
    Am J Surg Pathol; 2020 Aug; 44(8):1040-1049. PubMed ID: 32282346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate Cancer in Male-to-Female Transgender Individuals: Histopathologic Findings and Association With Gender-affirming Hormonal Therapy.
    Baraban E; Ding CC; White M; Vohra P; Simko J; Boyle K; Guo C; Zhang M; Dobs A; Ketheeswaran S; Liang F; Epstein JI
    Am J Surg Pathol; 2022 Dec; 46(12):1650-1658. PubMed ID: 36006769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histologic Features of Hysterectomy Specimens From Female-Male Transgender Individuals.
    Khalifa MA; Toyama A; Klein ME; Santiago V
    Int J Gynecol Pathol; 2019 Nov; 38(6):520-527. PubMed ID: 30252728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total vaginectomy and urethral lengthening at time of neourethral prelamination in transgender men.
    Medina CA; Fein LA; Salgado CJ
    Int Urogynecol J; 2018 Oct; 29(10):1463-1468. PubMed ID: 29188324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omission of Pelvic Examination Before Gender-Affirming Hysterectomy and Vaginectomy.
    Murphy EC; Kim Y; Weinstein MM
    Obstet Gynecol; 2023 Jun; 141(6):1160-1162. PubMed ID: 37144680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine Screening for Transgender and Gender Diverse Adults Taking Gender-Affirming Hormone Therapy: a Narrative Review.
    Iwamoto SJ; Grimstad F; Irwig MS; Rothman MS
    J Gen Intern Med; 2021 May; 36(5):1380-1389. PubMed ID: 33547576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoting Health Equality and Nondiscrimination for Transgender and Gender-Diverse Youth.
    Society for Adolescent Health and Medicine
    J Adolesc Health; 2020 Jun; 66(6):761-765. PubMed ID: 32473724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender-affirming Vaginectomy-Transperineal Approach.
    Hougen HY; Shoureshi PS; Sajadi KP
    Urology; 2020 Oct; 144():263-265. PubMed ID: 32645370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mental Healthcare Utilization of Transgender Youth Before and After Affirming Treatment.
    Hisle-Gorman E; Schvey NA; Adirim TA; Rayne AK; Susi A; Roberts TA; Klein DA
    J Sex Med; 2021 Aug; 18(8):1444-1454. PubMed ID: 34247956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial Cancer in a Transgender Man with Prolonged Exogenous Testosterone Use.
    Gill S; Anderson M; Neveu J
    Obstet Gynecol; 2024 Apr; 143(4):e125-e128. PubMed ID: 38330401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic Findings in Surgical Pathology Specimens From Individuals Taking Feminizing Hormone Therapy for the Purpose of Gender Transition.
    Andrews AR; Kakadekar A; Schmidt RL; Murugan P; Greene DN
    Arch Pathol Lab Med; 2022 Jan; 146(2):252-261. PubMed ID: 33983412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex Assigned at Birth Ratio Among Transgender and Gender Diverse Adolescents in the United States.
    Turban JL; Dolotina B; King D; Keuroghlian AS
    Pediatrics; 2022 Sep; 150(3):. PubMed ID: 35918512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic Findings in Surgical Pathology Specimens From Individuals Taking Masculinizing Hormone Therapy for the Purpose of Gender Transition.
    Andrews AR; Kakadekar A; Greene DN; Khalifa MA; Santiago V; Schmidt RL
    Arch Pathol Lab Med; 2022 Jun; 146(6):766-779. PubMed ID: 34559874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men.
    Pirtea P; Ayoubi JM; Desmedt S; T'Sjoen G
    Fertil Steril; 2021 Oct; 116(4):936-942. PubMed ID: 34481638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Gonadotropin-Releasing Hormone Analogue Use With Subsequent Use of Gender-Affirming Hormones Among Transgender Adolescents.
    Nos AL; Klein DA; Adirim TA; Schvey NA; Hisle-Gorman E; Susi A; Roberts CM
    JAMA Netw Open; 2022 Nov; 5(11):e2239758. PubMed ID: 36318207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Mortality Among Transgender and Gender Diverse Adults in England.
    Jackson SS; Brown J; Pfeiffer RM; Shrewsbury D; O'Callaghan S; Berner AM; Gadalla SM; Shiels MS
    JAMA Netw Open; 2023 Jan; 6(1):e2253687. PubMed ID: 36716027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oestrogen and anti-androgen therapy for transgender women.
    Tangpricha V; den Heijer M
    Lancet Diabetes Endocrinol; 2017 Apr; 5(4):291-300. PubMed ID: 27916515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histologic Findings in Gynecologic Tissue From Transmasculine Individuals Undergoing Gender-Affirming Surgery.
    Lin LH; Hernandez A; Marcus A; Deng FM; Adler E
    Arch Pathol Lab Med; 2022 Jun; 146(6):742-748. PubMed ID: 34591101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.